project id: TCGA-CESC; case submitter id: TCGA-EK-A2RK; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.4; age at index: 67; days to birth: -24541; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 24541; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 13.0; figo stage: Stage IA2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 709; initial weight: 120.0; oct embedded: false; preservation method: Unknown; sample id: b51d8c9b-f387-4e28-a592-b53fe6c2fd8b; sample submitter id: TCGA-EK-A2RK-01A; portion id: 2eba3f8b-11ac-4f75-b837-5d209ff9a504; portion submitter id: TCGA-EK-A2RK-01A-11; slide id: e459116a-acaf-4139-83b4-cb2f99b5722c; slide submitter id: TCGA-EK-A2RK-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 37.0; percent stromal cells: 10.0; percent tumor cells: 50.0; percent tumor nuclei: 70.0; section location: TOP;